还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

( A1 f( w/ B& W2 B3 p; [                               
登录/注册后可看大图

5 z/ K$ [5 @0 t请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  
# [+ J3 O4 A# u% k$ M6 ?
: d" J' E0 L6 U( y
3 h( ?" K2 W% @! \) Y5 u0 {Sub-category:
) x) Z: ]) ^$ v6 P/ [+ u2 u- F/ _Molecular Targets
$ G- w; H7 c& s/ [1 g- u/ z0 K+ o

* I8 g3 s/ P5 }2 hCategory:
Tumor Biology


Meeting:
+ Y8 \; r8 ~8 E$ I' \6 z8 U2011 ASCO Annual Meeting
1 ^8 `1 p) _& Z4 E

Session Type and Session Title:
Poster Discussion Session, Tumor Biology
6 C; o; S) A5 b) f$ c
& A. I$ m! K+ D0 v
Abstract No:
10517
3 y, ?( m8 ?. k1 r. u7 C

* j- y" t' ~8 F- u$ |8 P; t* P* qCitation:
- f% e3 n0 ?) H; J. UJ Clin Oncol 29: 2011 (suppl; abstr 10517)
' H0 d. Y4 v* ?9 b
" y1 U( N$ T3 D- M
  A  |  r" ^9 X  \Author(s):
J. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China

- S, y+ X# P+ C2 B1 t

Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.
3 w- g/ J8 P* ?+ p9 b
Abstract Disclosures

" T/ n% b! l, q7 AAbstract:

$ Y. ]$ V( o1 _) I9 R( g/ ?! V3 Q
Background: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.
/ N7 \$ E% [! t. i# S, b) w0 \

/ k  L! N0 u% Z( N

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

$ c/ ]. Y3 M- ]1 `5 D4 n3 O4 o                               
登录/注册后可看大图

( _: M% @* W7 A- ~7 X没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

6 T1 X2 n/ ~3 p7 B' B. n5 A! N/ ?3 ^# l                               
登录/注册后可看大图

- U6 Q# |1 v3 a& A易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
ALK一个指标医院要900多 ...

平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？
7 g* p9 Y8 }' |. F/ @* n9 z( U
现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊